ID   BAT1_HUMAN              Reviewed;         487 AA.
AC   P82251; B2R9A6;
DT   24-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   15-MAR-2017, entry version 165.
DE   RecName: Full=b(0,+)-type amino acid transporter 1;
DE            Short=b(0,+)AT1;
DE   AltName: Full=Glycoprotein-associated amino acid transporter b0,+AT1;
DE   AltName: Full=Solute carrier family 7 member 9;
GN   Name=SLC7A9; Synonyms=BAT1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], VARIANTS CSNU ARG-105; MET-170; THR-182;
RP   ARG-195 AND ARG-259, CHARACTERIZATION OF VARIANT CSNU MET-170,
RP   FUNCTION, AND TISSUE SPECIFICITY.
RC   TISSUE=Kidney;
RX   PubMed=10471498; DOI=10.1038/12652;
RA   Feliubadalo L., Font M., Purroy J., Rousaud F., Estivill X., Nunes V.,
RA   Golomb E., Centola M., Aksentijevich I., Kreiss Y., Goldman B.,
RA   Pras M., Kastner D.L., Pras E., Gasparini P., Bisceglia L., Beccia E.,
RA   Gallucci M., De Sanctis L., Ponzone A., Rizzoni G.F., Zelante L.,
RA   Bassi M.T., George A.L. Jr., Manzoni M., De Grandi A., Riboni M.,
RA   Endsley J.K., Ballabio A., Borsani G., Reig N., Fernandez E.,
RA   Estevez R., Pineda M., Torrents D., Camps M., Lloberas J., Zorzano A.,
RA   Palacin M.;
RT   "Non-type I cystinuria caused by mutations in SLC7A9, encoding a
RT   subunit (b0,+AT) of rBAT.";
RL   Nat. Genet. 23:52-57(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND FUNCTION.
RC   TISSUE=Kidney;
RX   PubMed=10588648; DOI=10.1091/mbc.10.12.4135;
RA   Pfeiffer R., Loffing J., Rossier G., Bauch C., Meier C., Eggermann T.,
RA   Loffing-Cueni D., Kuehn L.C., Verrey F.;
RT   "Luminal heterodimeric amino acid transporter defective in
RT   cystinuria.";
RL   Mol. Biol. Cell 10:4135-4147(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Kidney;
RX   PubMed=11318953; DOI=10.1046/j.1523-1755.2001.0590051821.x;
RA   Mizoguchi K., Cha S.H., Chairoungdua A., Kim J.Y., Shigeta Y.,
RA   Matsuo H., Fukushima J., Awa Y., Akakura K., Goya T., Ito H.,
RA   Endou H., Kanai Y.;
RT   "Human cystinuria-related transporter: localization and functional
RT   characterization.";
RL   Kidney Int. 59:1821-1833(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS CSNU THR-44; LEU-261 AND
RP   THR-354, AND VARIANT MET-223.
RX   PubMed=12371955; DOI=10.1046/j.1523-1755.2002.00602.x;
RA   Leclerc D., Boutros M., Suh D., Wu Q., Palacin M., Ellis J.R.,
RA   Goodyer P., Rozen R.;
RT   "SLC7A9 mutations in all three cystinuria subtypes.";
RL   Kidney Int. 62:1550-1559(2002).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   SUBUNIT, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=12167606;
RA   Fernandez E., Carrascal M., Rousaud F., Abian J., Zorzano A.,
RA   Palacin M., Chillaron J.;
RT   "rBAT-b(0,+)AT heterodimer is the main apical reabsorption system for
RT   cystine in the kidney.";
RL   Am. J. Physiol. 283:F540-F548(2002).
RN   [8]
RP   VARIANTS CSNU ARG-10 DEL; LEU-52; ARG-63; LEU-69; VAL-70; ARG-105;
RP   MET-123; THR-126; ALA-158 INS; MET-170; THR-182; PHE-187; ILE-193 INS;
RP   ARG-195; ARG-230; THR-241; GLU-244 DEL; ARG-259; TRP-333; THR-354;
RP   ARG-379 AND THR-382, AND CHARACTERIZATION OF VARIANTS CSNU VAL-70;
RP   ARG-105; MET-170; THR-182; TRP-333 AND THR-354.
RX   PubMed=11157794; DOI=10.1093/hmg/10.4.305;
RA   Font M., Feliubadalo L., Estivill X., Nunes V., Golomb E., Kreiss Y.,
RA   Pras E., Bisceglia L., d'Adamo A.P., Zelante L., Gasparini P.,
RA   Bassi M.T., George A.L. Jr., Manzoni M., Riboni M., Ballabio A.,
RA   Borsani G., Reig N., Fernandez E., Zorzano A., Bertran J., Palacin M.;
RT   "Functional analysis of mutations in SLC7A9, and genotype-phenotype
RT   correlation in non-type I cystinuria.";
RL   Hum. Mol. Genet. 10:305-316(2001).
RN   [9]
RP   VARIANTS CSNU ARG-105; VAL-224 AND VAL-331.
RX   PubMed=12234283; DOI=10.1046/j.1523-1755.2002.00552.x;
RA   Botzenhart E., Vester U., Schmidt C., Hesse A., Halber M., Wagner C.,
RA   Lang F., Hoyer P., Zerres K., Eggermann T.;
RT   "Cystinuria in children: distribution and frequencies of mutations in
RT   the SLC3A1 and SLC7A9 genes.";
RL   Kidney Int. 62:1136-1142(2002).
RN   [10]
RP   VARIANTS CSNU THR-182; LEU-261 AND MET-330.
RX   PubMed=12820697; DOI=10.1089/109065703321560886;
RA   Harnevik L., Fjellstedt E., Molbaek A., Denneberg T., Soderkvist P.;
RT   "Mutation analysis of SLC7A9 in cystinuria patients in Sweden.";
RL   Genet. Test. 7:13-20(2003).
RN   [11]
RP   VARIANTS CSNU ARG-105; MET-123; ARG-319 AND TRP-333.
RX   PubMed=16138908; DOI=10.1111/j.1529-8817.2005.00185.x;
RA   Skopkova Z., Hrabincova E., Stastna S., Kozak L., Adam T.;
RT   "Molecular genetic analysis of SLC3A1 and SLC7A9 genes in Czech and
RT   Slovak cystinuric patients.";
RL   Ann. Hum. Genet. 69:501-507(2005).
RN   [12]
RP   VARIANTS CSNU MET-62; MET-188; CYS-232; PHE-283 AND VAL-316.
RX   PubMed=15635077; DOI=10.1136/jmg.2004.022244;
RA   Font-Llitjos M., Jimenez-Vidal M., Bisceglia L., Di Perna M.,
RA   de Sanctis L., Rousaud F., Zelante L., Palacin M., Nunes V.;
RT   "New insights into cystinuria: 40 new mutations, genotype-phenotype
RT   correlation, and digenic inheritance causing partial phenotype.";
RL   J. Med. Genet. 42:58-68(2005).
RN   [13]
RP   VARIANTS CSNU ARG-195; ASP-227; GLN-333 AND LEU-482, CHARACTERIZATION
RP   OF VARIANTS CSNU ARG-195; ASP-227; GLN-333 AND LEU-482, VARIANTS
RP   ALA-142 AND MET-223, CHARACTERIZATION OF VARIANTS ALA-142 AND MET-223,
RP   FUNCTION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF PRO-482.
RX   PubMed=16609684; DOI=10.1038/sj.ki.5000241;
RA   Shigeta Y., Kanai Y., Chairoungdua A., Ahmed N., Sakamoto S.,
RA   Matsuo H., Kim D.K., Fujimura M., Anzai N., Mizoguchi K., Ueda T.,
RA   Akakura K., Ichikawa T., Ito H., Endou H.;
RT   "A novel missense mutation of SLC7A9 frequent in Japanese cystinuria
RT   cases affecting the C-terminus of the transporter.";
RL   Kidney Int. 69:1198-1206(2006).
RN   [14]
RP   VARIANTS CSNU MET-40; PHE-51; HIS-99; ARG-114; LEU-120; PHE-286;
RP   GLU-324; GLU-401 AND PRO-426.
RX   PubMed=18752446; DOI=10.1089/gte.2007.0113;
RA   Di Perna M., Louizou E., Fischetti L., Dedoussis G.V., Stanziale P.,
RA   Michelakakis H., Zelante L., Pras E., Bisceglia L.;
RT   "Twenty-four novel mutations identified in a cohort of 85 patients by
RT   direct sequencing of the SLC3A1 and SLC7A9 cystinuria genes.";
RL   Genet. Test. 12:351-355(2008).
RN   [15]
RP   VARIANTS CSNU ARG-105; GLU-105; MET-123; THR-182 AND LYS-250.
RX   PubMed=19782624; DOI=10.1016/j.ymgme.2009.09.001;
RA   Bisceglia L., Fischetti L., Bonis P.D., Palumbo O., Augello B.,
RA   Stanziale P., Carella M., Zelante L.;
RT   "Large rearrangements detected by MLPA, point mutations, and survey of
RT   the frequency of mutations within the SLC3A1 and SLC7A9 genes in a
RT   cohort of 172 cystinuric Italian patients.";
RL   Mol. Genet. Metab. 99:42-52(2010).
CC   -!- FUNCTION: Involved in the high-affinity, sodium-independent
CC       transport of cystine and neutral and dibasic amino acids (system
CC       b(0,+)-like activity). Thought to be responsible for the high-
CC       affinity reabsorption of cystine in the kidney tubule.
CC       {ECO:0000269|PubMed:10471498, ECO:0000269|PubMed:10588648,
CC       ECO:0000269|PubMed:16609684}.
CC   -!- SUBUNIT: Disulfide-linked heterodimer with the amino acid
CC       transport protein SLC3A1. Interacts with CAV1.
CC       {ECO:0000250|UniProtKB:P82252}.
CC   -!- INTERACTION:
CC       O43889-2:CREB3; NbExp=3; IntAct=EBI-3936589, EBI-625022;
CC   -!- SUBCELLULAR LOCATION: Apical cell membrane
CC       {ECO:0000269|PubMed:12167606, ECO:0000269|PubMed:16609684}; Multi-
CC       pass membrane protein {ECO:0000269|PubMed:16609684,
CC       ECO:0000305|PubMed:12167606}.
CC   -!- TISSUE SPECIFICITY: Expressed in the brush border membrane in the
CC       kidney (at protein level). Kidney, small intestine, liver and
CC       placenta. {ECO:0000269|PubMed:10471498,
CC       ECO:0000269|PubMed:12167606}.
CC   -!- DISEASE: Cystinuria (CSNU) [MIM:220100]: An autosomal disorder
CC       characterized by impaired epithelial cell transport of cystine and
CC       dibasic amino acids (lysine, ornithine, and arginine) in the
CC       proximal renal tubule and gastrointestinal tract. The impaired
CC       renal reabsorption of cystine and its low solubility causes the
CC       formation of calculi in the urinary tract, resulting in
CC       obstructive uropathy, pyelonephritis, and, rarely, renal failure.
CC       {ECO:0000269|PubMed:10471498, ECO:0000269|PubMed:11157794,
CC       ECO:0000269|PubMed:12234283, ECO:0000269|PubMed:12371955,
CC       ECO:0000269|PubMed:12820697, ECO:0000269|PubMed:15635077,
CC       ECO:0000269|PubMed:16138908, ECO:0000269|PubMed:16609684,
CC       ECO:0000269|PubMed:18752446, ECO:0000269|PubMed:19782624}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the amino acid-polyamine-organocation (APC)
CC       superfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF141289; AAD55898.1; -; mRNA.
DR   EMBL; AJ249199; CAB54003.1; -; mRNA.
DR   EMBL; AB033548; BAB16840.1; -; mRNA.
DR   EMBL; AF421181; AAN40878.1; -; Genomic_DNA.
DR   EMBL; AF421170; AAN40878.1; JOINED; Genomic_DNA.
DR   EMBL; AF421171; AAN40878.1; JOINED; Genomic_DNA.
DR   EMBL; AF421172; AAN40878.1; JOINED; Genomic_DNA.
DR   EMBL; AF421173; AAN40878.1; JOINED; Genomic_DNA.
DR   EMBL; AF421174; AAN40878.1; JOINED; Genomic_DNA.
DR   EMBL; AF421175; AAN40878.1; JOINED; Genomic_DNA.
DR   EMBL; AF421176; AAN40878.1; JOINED; Genomic_DNA.
DR   EMBL; AF421177; AAN40878.1; JOINED; Genomic_DNA.
DR   EMBL; AF421178; AAN40878.1; JOINED; Genomic_DNA.
DR   EMBL; AF421179; AAN40878.1; JOINED; Genomic_DNA.
DR   EMBL; AF421180; AAN40878.1; JOINED; Genomic_DNA.
DR   EMBL; AK313708; BAG36453.1; -; mRNA.
DR   EMBL; BC017962; AAH17962.1; -; mRNA.
DR   CCDS; CCDS12425.1; -.
DR   RefSeq; NP_001119807.1; NM_001126335.1.
DR   RefSeq; NP_001229965.1; NM_001243036.1.
DR   RefSeq; NP_055085.1; NM_014270.4.
DR   RefSeq; XP_011524704.1; XM_011526402.2.
DR   UniGene; Hs.743345; -.
DR   ProteinModelPortal; P82251; -.
DR   BioGrid; 116309; 3.
DR   IntAct; P82251; 4.
DR   MINT; MINT-3023541; -.
DR   STRING; 9606.ENSP00000023064; -.
DR   DrugBank; DB00138; L-Cystine.
DR   TCDB; 2.A.3.8.19; the amino acid-polyamine-organocation (apc) family.
DR   iPTMnet; P82251; -.
DR   PhosphoSitePlus; P82251; -.
DR   SwissPalm; P82251; -.
DR   BioMuta; SLC7A9; -.
DR   DMDM; 12585187; -.
DR   PaxDb; P82251; -.
DR   PeptideAtlas; P82251; -.
DR   PRIDE; P82251; -.
DR   DNASU; 11136; -.
DR   Ensembl; ENST00000023064; ENSP00000023064; ENSG00000021488.
DR   Ensembl; ENST00000587772; ENSP00000468439; ENSG00000021488.
DR   Ensembl; ENST00000590341; ENSP00000464822; ENSG00000021488.
DR   GeneID; 11136; -.
DR   KEGG; hsa:11136; -.
DR   UCSC; uc002ntu.6; human.
DR   CTD; 11136; -.
DR   DisGeNET; 11136; -.
DR   GeneCards; SLC7A9; -.
DR   HGNC; HGNC:11067; SLC7A9.
DR   HPA; HPA042591; -.
DR   MalaCards; SLC7A9; -.
DR   MIM; 220100; phenotype.
DR   MIM; 604144; gene.
DR   neXtProt; NX_P82251; -.
DR   OpenTargets; ENSG00000021488; -.
DR   Orphanet; 93613; Cystinuria type B.
DR   PharmGKB; PA35927; -.
DR   eggNOG; KOG1287; Eukaryota.
DR   eggNOG; COG0531; LUCA.
DR   GeneTree; ENSGT00760000119037; -.
DR   HOGENOM; HOG000098892; -.
DR   HOVERGEN; HBG000476; -.
DR   InParanoid; P82251; -.
DR   KO; K13868; -.
DR   OMA; SFSEYVC; -.
DR   OrthoDB; EOG091G07EM; -.
DR   PhylomeDB; P82251; -.
DR   Reactome; R-HSA-210991; Basigin interactions.
DR   Reactome; R-HSA-352230; Amino acid transport across the plasma membrane.
DR   GenomeRNAi; 11136; -.
DR   PRO; PR:P82251; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000021488; -.
DR   CleanEx; HS_BAT1; -.
DR   CleanEx; HS_SLC7A9; -.
DR   ExpressionAtlas; P82251; baseline and differential.
DR   Genevisible; P82251; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:UniProtKB.
DR   GO; GO:0031526; C:brush border membrane; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0015297; F:antiporter activity; IBA:GO_Central.
DR   GO; GO:0015184; F:L-cystine transmembrane transporter activity; IMP:UniProtKB.
DR   GO; GO:0015175; F:neutral amino acid transmembrane transporter activity; IMP:UniProtKB.
DR   GO; GO:0042605; F:peptide antigen binding; ISS:UniProtKB.
DR   GO; GO:0006865; P:amino acid transport; TAS:Reactome.
DR   GO; GO:0015811; P:L-cystine transport; IMP:UniProtKB.
DR   GO; GO:0050900; P:leukocyte migration; TAS:Reactome.
DR   GO; GO:0015804; P:neutral amino acid transport; IMP:UniProtKB.
DR   GO; GO:0006461; P:protein complex assembly; TAS:ProtInc.
DR   InterPro; IPR002293; AA/rel_permease1.
DR   Pfam; PF13520; AA_permease_2; 1.
DR   PIRSF; PIRSF006060; AA_transporter; 1.
PE   1: Evidence at protein level;
KW   Amino-acid transport; Cell membrane; Complete proteome; Cystinuria;
KW   Disease mutation; Disulfide bond; Membrane; Phosphoprotein;
KW   Polymorphism; Reference proteome; Transmembrane; Transmembrane helix;
KW   Transport.
FT   CHAIN         1    487       b(0,+)-type amino acid transporter 1.
FT                                /FTId=PRO_0000054258.
FT   TOPO_DOM      1     29       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     30     50       Helical. {ECO:0000255}.
FT   TOPO_DOM     51     60       Extracellular. {ECO:0000255}.
FT   TRANSMEM     61     81       Helical. {ECO:0000255}.
FT   TOPO_DOM     82     99       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    100    120       Helical. {ECO:0000255}.
FT   TOPO_DOM    121    148       Extracellular. {ECO:0000255}.
FT   TRANSMEM    149    169       Helical. {ECO:0000255}.
FT   TOPO_DOM    170    178       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    179    199       Helical. {ECO:0000255}.
FT   TOPO_DOM    200    210       Extracellular. {ECO:0000255}.
FT   TRANSMEM    211    231       Helical. {ECO:0000255}.
FT   TOPO_DOM    232    251       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    252    272       Helical. {ECO:0000255}.
FT   TOPO_DOM    273    296       Extracellular. {ECO:0000255}.
FT   TRANSMEM    297    317       Helical. {ECO:0000255}.
FT   TOPO_DOM    318    348       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    349    369       Helical. {ECO:0000255}.
FT   TOPO_DOM    370    374       Extracellular. {ECO:0000255}.
FT   TRANSMEM    375    395       Helical. {ECO:0000255}.
FT   TOPO_DOM    396    409       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    410    430       Helical. {ECO:0000255}.
FT   TOPO_DOM    431    434       Extracellular. {ECO:0000255}.
FT   TRANSMEM    435    455       Helical. {ECO:0000255}.
FT   TOPO_DOM    456    487       Cytoplasmic. {ECO:0000255}.
FT   MOD_RES      18     18       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P82252}.
FT   VARIANT      10     10       Missing (in CSNU).
FT                                {ECO:0000269|PubMed:11157794}.
FT                                /FTId=VAR_018997.
FT   VARIANT      40     40       V -> M (in CSNU; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:18752446}.
FT                                /FTId=VAR_072308.
FT   VARIANT      44     44       I -> T (in CSNU; type I;
FT                                dbSNP:rs121908485).
FT                                {ECO:0000269|PubMed:12371955}.
FT                                /FTId=VAR_014363.
FT   VARIANT      51     51       S -> F (in CSNU; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:18752446}.
FT                                /FTId=VAR_072309.
FT   VARIANT      52     52       P -> L (in CSNU).
FT                                {ECO:0000269|PubMed:11157794}.
FT                                /FTId=VAR_018998.
FT   VARIANT      62     62       V -> M (in CSNU).
FT                                {ECO:0000269|PubMed:15635077}.
FT                                /FTId=VAR_072310.
FT   VARIANT      63     63       G -> R (in CSNU).
FT                                {ECO:0000269|PubMed:11157794}.
FT                                /FTId=VAR_018999.
FT   VARIANT      69     69       W -> L (in CSNU).
FT                                {ECO:0000269|PubMed:11157794}.
FT                                /FTId=VAR_019000.
FT   VARIANT      70     70       A -> V (in CSNU; mild loss of amino acid
FT                                transport activity; dbSNP:rs769448665).
FT                                {ECO:0000269|PubMed:11157794}.
FT                                /FTId=VAR_019001.
FT   VARIANT      99     99       Y -> H (in CSNU; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:18752446}.
FT                                /FTId=VAR_072311.
FT   VARIANT     105    105       G -> E (in CSNU).
FT                                {ECO:0000269|PubMed:19782624}.
FT                                /FTId=VAR_072312.
FT   VARIANT     105    105       G -> R (in CSNU; type III; frequent
FT                                mutation; severe loss of amino acid
FT                                transport activity; dbSNP:rs121908480).
FT                                {ECO:0000269|PubMed:10471498,
FT                                ECO:0000269|PubMed:11157794,
FT                                ECO:0000269|PubMed:12234283,
FT                                ECO:0000269|PubMed:16138908,
FT                                ECO:0000269|PubMed:19782624}.
FT                                /FTId=VAR_010256.
FT   VARIANT     114    114       W -> R (in CSNU; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:18752446}.
FT                                /FTId=VAR_072313.
FT   VARIANT     120    120       I -> L (in CSNU; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:18752446}.
FT                                /FTId=VAR_072314.
FT   VARIANT     123    123       T -> M (in CSNU; dbSNP:rs79987078).
FT                                {ECO:0000269|PubMed:11157794,
FT                                ECO:0000269|PubMed:16138908,
FT                                ECO:0000269|PubMed:19782624}.
FT                                /FTId=VAR_019002.
FT   VARIANT     126    126       A -> T (in CSNU; dbSNP:rs372306844).
FT                                {ECO:0000269|PubMed:11157794}.
FT                                /FTId=VAR_019003.
FT   VARIANT     142    142       V -> A (common polymorphism; no effect on
FT                                amino acid transport activity;
FT                                dbSNP:rs12150889).
FT                                {ECO:0000269|PubMed:16609684}.
FT                                /FTId=VAR_048153.
FT   VARIANT     158    158       A -> AA (in CSNU).
FT                                {ECO:0000269|PubMed:11157794}.
FT                                /FTId=VAR_019004.
FT   VARIANT     170    170       V -> M (in CSNU; type III; frequent
FT                                mutation; complete loss of amino acid
FT                                transport activity; dbSNP:rs121908479).
FT                                {ECO:0000269|PubMed:10471498,
FT                                ECO:0000269|PubMed:11157794}.
FT                                /FTId=VAR_010257.
FT   VARIANT     182    182       A -> T (in CSNU; type III; frequent
FT                                mutation; mild loss of amino acid
FT                                transport activity; dbSNP:rs79389353).
FT                                {ECO:0000269|PubMed:10471498,
FT                                ECO:0000269|PubMed:11157794,
FT                                ECO:0000269|PubMed:12820697,
FT                                ECO:0000269|PubMed:19782624}.
FT                                /FTId=VAR_010258.
FT   VARIANT     187    187       I -> F (in CSNU; dbSNP:rs368441237).
FT                                {ECO:0000269|PubMed:11157794}.
FT                                /FTId=VAR_019005.
FT   VARIANT     188    188       V -> M (in CSNU; dbSNP:rs531029519).
FT                                {ECO:0000269|PubMed:15635077}.
FT                                /FTId=VAR_072315.
FT   VARIANT     193    193       I -> II (in CSNU).
FT                                {ECO:0000269|PubMed:11157794}.
FT                                /FTId=VAR_019006.
FT   VARIANT     195    195       G -> R (in CSNU; type III; decreased
FT                                amino acid transport activity;
FT                                dbSNP:rs121908482).
FT                                {ECO:0000269|PubMed:10471498,
FT                                ECO:0000269|PubMed:11157794,
FT                                ECO:0000269|PubMed:16609684}.
FT                                /FTId=VAR_010259.
FT   VARIANT     223    223       L -> M (common polymorphism; slightly
FT                                decreased amino acid transport activity;
FT                                dbSNP:rs1007160).
FT                                {ECO:0000269|PubMed:12371955,
FT                                ECO:0000269|PubMed:16609684}.
FT                                /FTId=VAR_019007.
FT   VARIANT     224    224       A -> V (in CSNU; non-classic type I;
FT                                dbSNP:rs140873167).
FT                                {ECO:0000269|PubMed:12234283}.
FT                                /FTId=VAR_022603.
FT   VARIANT     227    227       N -> D (in CSNU; decreased amino acid
FT                                transport activity).
FT                                {ECO:0000269|PubMed:16609684}.
FT                                /FTId=VAR_072316.
FT   VARIANT     230    230       W -> R (in CSNU).
FT                                {ECO:0000269|PubMed:11157794}.
FT                                /FTId=VAR_019008.
FT   VARIANT     232    232       Y -> C (in CSNU; dbSNP:rs121908487).
FT                                {ECO:0000269|PubMed:15635077}.
FT                                /FTId=VAR_072317.
FT   VARIANT     241    241       I -> T (in CSNU; dbSNP:rs777371504).
FT                                {ECO:0000269|PubMed:11157794}.
FT                                /FTId=VAR_019009.
FT   VARIANT     244    244       Missing (in CSNU).
FT                                {ECO:0000269|PubMed:11157794}.
FT                                /FTId=VAR_019010.
FT   VARIANT     250    250       R -> K (in CSNU; dbSNP:rs766529640).
FT                                {ECO:0000269|PubMed:19782624}.
FT                                /FTId=VAR_072318.
FT   VARIANT     259    259       G -> R (in CSNU; type III;
FT                                dbSNP:rs121908483).
FT                                {ECO:0000269|PubMed:10471498,
FT                                ECO:0000269|PubMed:11157794}.
FT                                /FTId=VAR_010260.
FT   VARIANT     261    261       P -> L (in CSNU; types I and III;
FT                                dbSNP:rs121908486).
FT                                {ECO:0000269|PubMed:12371955,
FT                                ECO:0000269|PubMed:12820697}.
FT                                /FTId=VAR_014364.
FT   VARIANT     283    283       L -> F (in CSNU).
FT                                {ECO:0000269|PubMed:15635077}.
FT                                /FTId=VAR_072319.
FT   VARIANT     286    286       S -> F (in CSNU; unknown pathological
FT                                significance; dbSNP:rs755135545).
FT                                {ECO:0000269|PubMed:18752446}.
FT                                /FTId=VAR_072320.
FT   VARIANT     316    316       A -> V (in CSNU).
FT                                {ECO:0000269|PubMed:15635077}.
FT                                /FTId=VAR_072321.
FT   VARIANT     319    319       G -> R (in CSNU).
FT                                {ECO:0000269|PubMed:16138908}.
FT                                /FTId=VAR_072322.
FT   VARIANT     324    324       A -> E (in CSNU; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:18752446}.
FT                                /FTId=VAR_072323.
FT   VARIANT     330    330       V -> M (in CSNU; type III;
FT                                dbSNP:rs201618022).
FT                                {ECO:0000269|PubMed:12820697}.
FT                                /FTId=VAR_015885.
FT   VARIANT     331    331       A -> V (in CSNU; non-classic type I;
FT                                dbSNP:rs768466784).
FT                                {ECO:0000269|PubMed:12234283}.
FT                                /FTId=VAR_022604.
FT   VARIANT     333    333       R -> Q (in CSNU; decreased amino acid
FT                                transport activity; dbSNP:rs769576205).
FT                                {ECO:0000269|PubMed:16609684}.
FT                                /FTId=VAR_072324.
FT   VARIANT     333    333       R -> W (in CSNU; frequent mutation;
FT                                severe loss of amino acid transport
FT                                activity; dbSNP:rs121908484).
FT                                {ECO:0000269|PubMed:11157794,
FT                                ECO:0000269|PubMed:16138908}.
FT                                /FTId=VAR_019011.
FT   VARIANT     354    354       A -> T (in CSNU; type III; severe loss of
FT                                amino acid transport activity).
FT                                {ECO:0000269|PubMed:11157794,
FT                                ECO:0000269|PubMed:12371955}.
FT                                /FTId=VAR_014365.
FT   VARIANT     379    379       S -> R (in CSNU; dbSNP:rs142270619).
FT                                {ECO:0000269|PubMed:11157794}.
FT                                /FTId=VAR_019012.
FT   VARIANT     382    382       A -> T (in CSNU; dbSNP:rs774878350).
FT                                {ECO:0000269|PubMed:11157794}.
FT                                /FTId=VAR_019013.
FT   VARIANT     401    401       K -> E (in CSNU; unknown pathological
FT                                significance; dbSNP:rs760264924).
FT                                {ECO:0000269|PubMed:18752446}.
FT                                /FTId=VAR_072325.
FT   VARIANT     426    426       L -> P (in CSNU; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:18752446}.
FT                                /FTId=VAR_072326.
FT   VARIANT     482    482       P -> L (in CSNU; decreased amino acid
FT                                transport activity; no effect on
FT                                localization to the apical membrane;
FT                                dbSNP:rs146815072).
FT                                {ECO:0000269|PubMed:16609684}.
FT                                /FTId=VAR_072327.
FT   MUTAGEN     482    482       P->A,G,S,V: No effect on amino acid
FT                                transport activity.
FT                                {ECO:0000269|PubMed:16609684}.
FT   MUTAGEN     482    482       P->F,I,M,W: Decreased amino acid
FT                                transport activity.
FT                                {ECO:0000269|PubMed:16609684}.
FT   CONFLICT     52     52       P -> S (in Ref. 2; CAB54003).
FT                                {ECO:0000305}.
SQ   SEQUENCE   487 AA;  53481 MW;  EF2C30DDE15594F1 CRC64;
     MGDTGLRKRR EDEKSIQSQE PKTTSLQKEL GLISGISIIV GTIIGSGIFV SPKSVLSNTE
     AVGPCLIIWA ACGVLATLGA LCFAELGTMI TKSGGEYPYL MEAYGPIPAY LFSWASLIVI
     KPTSFAIICL SFSEYVCAPF YVGCKPPQIV VKCLAAAAIL FISTVNSLSV RLGSYVQNIF
     TAAKLVIVAI IIISGLVLLA QGNTKNFDNS FEGAQLSVGA ISLAFYNGLW AYDGWNQLNY
     ITEELRNPYR NLPLAIIIGI PLVTACYILM NVSYFTVMTA TELLQSQAVA VTFGDRVLYP
     ASWIVPLFVA FSTIGAANGT CFTAGRLIYV AGREGHMLKV LSYISVRRLT PAPAIIFYGI
     IATIYIIPGD INSLVNYFSF AAWLFYGLTI LGLIVMRFTR KELERPIKVP VVIPVLMTLI
     SVFLVLAPII SKPTWEYLYC VLFILSGLLF YFLFVHYKFG WAQKISKPIT MHLQMLMEVV
     PPEEDPE
//
